SGRY · Insider Trading
Surgery Partners, Inc. Common Stock
Every open-market purchase and sale reported by SGRY officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-20 | Teresa DeLuca | Director | Buy | +11,250 | +$161.21K |
| 2026-08-19 | Teresa DeLuca | Director | Buy | +10,000 | +$143.50K |
| 2026-07-14 | Blair E Hendrix | Director | A | +34,364 | +$500.00K |
| 2026-06-09 | Teresa DeLuca | Director | A | +11,670 | +$160.00K |
| 2026-06-09 | Brent Turner | Director | A | +11,670 | +$160.00K |
| 2026-06-09 | Blair E Hendrix | Director | A | +11,670 | +$160.00K |
| 2026-06-09 | Clifford G Adlerz | Director | A | +11,670 | +$160.00K |
| 2026-06-09 | John A Deane | Director | A | +11,670 | +$160.00K |
| 2026-06-09 | Laura L Forese | Director | A | +11,670 | +$160.00K |
| 2026-06-09 | Lloyd H Dean | Director | A | +11,670 | +$160.00K |
| 2026-03-16 | Jennifer Baldock | Chief Admin & Dev Officer | Sell | −5,798 | −$76.36K |
| 2026-03-16 | Marissa Brittenham | Chief Strategy Officer | Sell | −3,657 | −$45.86K |
| 2026-03-16 | Jason Eric Evans | Chief Executive Officer | Sell | −20,400 | −$254.39K |
| 2026-03-16 | Danielle Burkhalter | Chief Human Resources Officer | Sell | −3,469 | −$44.51K |
| 2026-03-16 | David T Doherty | Chief Financial Officer | Sell | −8,867 | −$110.84K |
| 2026-03-09 | Justin Robert Oppenheimer | COO & National Group President | A | +42,523 | +$600.00K |
| 2026-03-09 | William Trenton Webb | American Group President | MIXED | +29,826 | +$421.34K |
| 2026-03-09 | Danielle Burkhalter | Chief Human Resources Officer | MIXED | +35,494 | +$504.77K |
| 2026-03-09 | Jason Eric Evans | Chief Executive Officer | MIXED | +266,644 | +$3.77M |
| 2026-03-09 | Jennifer Baldock | Chief Admin & Dev Officer | MIXED | +96,225 | +$1.36M |
| 2026-03-09 | Marissa Brittenham | Chief Strategy Officer | MIXED | +34,445 | +$489.62K |
| 2026-03-09 | David T Doherty | Chief Financial Officer | MIXED | +127,169 | +$1.80M |
| 2026-01-15 | Justin Robert Oppenheimer | COO & National Group President | A | +77,736 | +$1.25M |
| 2025-09-08 | Harrison R. Bane | National Group President | Sell | −9,339 | −$209.94K |
| 2025-08-15 | Patricia Anne Maryland | Director | Sell | — | — |
| 2025-08-15 | Teresa DeLuca | Director | Sell | −20,018 | −$455.21K |
| 2025-08-13 | Patricia Anne Maryland | Director | Sell | −20,018 | −$455.21K |
| 2025-08-08 | David T Doherty | Chief Financial Officer | Sell | −47,491 | −$1.11M |
| 2025-06-12 | Brent Turner | Director | A | +6,861 | +$160.00K |
| 2025-06-12 | Patricia Anne Maryland | Director | A | +6,861 | +$160.00K |
| 2025-06-12 | Clifford G Adlerz | Director | A | +6,861 | +$160.00K |
| 2025-06-12 | Laura L Forese | Director | A | +6,861 | +$160.00K |
| 2025-06-12 | John A Deane | Director | A | +6,861 | +$160.00K |
| 2025-06-12 | Blair E Hendrix | Director | A | +6,861 | +$160.00K |
| 2025-06-12 | Teresa DeLuca | Director | A | +6,861 | +$160.00K |
| 2025-03-25 | Wayne S DeVeydt | Exec Chairman of the Board | A | +4,233 | +$102.48K |
| 2025-03-17 | William Trenton Webb | American Group President | Sell | −138 | −$3.27K |
| 2025-03-17 | Jennifer Baldock | Chief Admin & Dev Officer | Sell | −612 | −$14.65K |
| 2025-03-17 | Danielle Burkhalter | Chief Human Resources Officer | Sell | −74 | −$1.76K |
| 2025-03-13 | Marissa Brittenham | Chief Strategy Officer | Sell | −3,156 | −$76.03K |
| 2025-03-13 | Jennifer Baldock | Chief Admin & Dev Officer | Sell | −3,008 | −$72.10K |
| 2025-03-13 | David T Doherty | Chief Financial Officer | Sell | −6,733 | −$161.73K |
| 2025-03-13 | Harrison R. Bane | National Group President | Sell | −4,045 | −$97.73K |
| 2025-03-13 | William Trenton Webb | American Group President | Sell | −2,057 | −$49.49K |
| 2025-03-13 | Danielle Burkhalter | Chief Human Resources Officer | Sell | −1,240 | −$29.93K |
| 2025-03-06 | Danielle Burkhalter | Chief Human Resources Officer | A | +15,966 | +$379.99K |
| 2025-03-06 | Jennifer Baldock | Chief Admin & Dev Officer | A | +39,495 | +$939.98K |
| 2025-03-06 | David T Doherty | Chief Financial Officer | A | +48,739 | +$1.16M |
| 2025-03-06 | Marissa Brittenham | Chief Strategy Officer | A | +16,386 | +$389.99K |
| 2025-03-06 | Jason Eric Evans | Chief Executive Officer | A | +113,444 | +$2.70M |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Blair E Hendrix | Director | 49,999,867 | $1.16B |
| Jason Eric Evans | Chief Executive Officer | 920,386 | $21.40M |
| Jennifer Baldock | Chief Admin & Dev Officer | 326,474 | $7.59M |
| David T Doherty | Chief Financial Officer | 221,679 | $5.15M |
| Harrison R. Bane | National Group President | 120,794 | $2.81M |
| Justin Robert Oppenheimer | COO & National Group President | 120,259 | $2.80M |
| Wayne S DeVeydt | Exec Chairman of the Board | 105,203 | $2.45M |
| Marissa Brittenham | Chief Strategy Officer | 94,196 | $2.19M |
| Brent Turner | Director | 86,594 | $2.01M |
| Danielle Burkhalter | Chief Human Resources Officer | 76,864 | $1.79M |
| William Trenton Webb | American Group President | 74,249 | $1.73M |
| Clifford G Adlerz | Director | 69,104 | $1.61M |
| Teresa DeLuca | Director | 68,093 | $1.58M |
| John A Deane | Director | 45,922 | $1.07M |
| Patricia Anne Maryland | Director | 24,583 | $571.55K |
| Laura L Forese | Director | 18,531 | $430.85K |
| Lloyd H Dean | Director | 11,670 | $271.33K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SGRY quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.